200 related articles for article (PubMed ID: 25355420)
1. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.
Johnson WM; Yao C; Siedlak SL; Wang W; Zhu X; Caldwell GA; Wilson-Delfosse AL; Mieyal JJ; Chen SG
Hum Mol Genet; 2015 Mar; 24(5):1322-35. PubMed ID: 25355420
[TBL] [Abstract][Full Text] [Related]
2. Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.
Yao C; Johnson WM; Gao Y; Wang W; Zhang J; Deak M; Alessi DR; Zhu X; Mieyal JJ; Roder H; Wilson-Delfosse AL; Chen SG
Hum Mol Genet; 2013 Jan; 22(2):328-44. PubMed ID: 23065705
[TBL] [Abstract][Full Text] [Related]
3. Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.
Chandler RJ; Cogo S; Lewis PA; Kevei E
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34397087
[TBL] [Abstract][Full Text] [Related]
4. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
[TBL] [Abstract][Full Text] [Related]
5. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
[TBL] [Abstract][Full Text] [Related]
6. Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.
Di Domenico F; Sultana R; Ferree A; Smith K; Barone E; Perluigi M; Coccia R; Pierce W; Cai J; Mancuso C; Squillace R; Wiengele M; Dalle-Donne I; Wolozin B; Butterfield DA
Antioxid Redox Signal; 2012 Dec; 17(11):1490-506. PubMed ID: 22315971
[TBL] [Abstract][Full Text] [Related]
7. Exploring Caenorhabditis elegans as Parkinson's Disease Model: Neurotoxins and Genetic Implications.
da Silva LPD; da Cruz Guedes E; Fernandes ICO; Pedroza LAL; da Silva Pereira GJ; Gubert P
Neurotox Res; 2024 Feb; 42(1):11. PubMed ID: 38319410
[TBL] [Abstract][Full Text] [Related]
8. Modeling Parkinson's Disease in C. elegans.
Cooper JF; Van Raamsdonk JM
J Parkinsons Dis; 2018; 8(1):17-32. PubMed ID: 29480229
[TBL] [Abstract][Full Text] [Related]
9. NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease.
Anantha J; Goulding SR; Tuboly E; O'Mahony AG; Moloney GM; Lomansey G; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
Mol Neurobiol; 2022 Jan; 59(1):61-76. PubMed ID: 34623600
[TBL] [Abstract][Full Text] [Related]
10. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
[TBL] [Abstract][Full Text] [Related]
11. Caenorhabditis elegans RAC1/ced-10 mutants as a new animal model to study very early stages of Parkinson's disease.
Muñoz-Juan A; Benseny-Cases N; Guha S; Barba I; Caldwell KA; Caldwell GA; Agulló L; Yuste VJ; Laromaine A; Dalfó E
Prog Neurobiol; 2024 Mar; 234():102572. PubMed ID: 38253120
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic expression of the Parkinsonian gene LRRK2-G2019S leads to non-autonomous visual neurodegeneration, accelerated by increased neural demands for energy.
Hindle S; Afsari F; Stark M; Middleton CA; Evans GJ; Sweeney ST; Elliott CJ
Hum Mol Genet; 2013 Jun; 22(11):2129-40. PubMed ID: 23396536
[TBL] [Abstract][Full Text] [Related]
14. Potential Therapeutic Effects of Policosanol from Insect Wax on Caenorhabditis elegans Models of Parkinson's Disease.
Ma C; Feng Y; Li X; Sun L; He Z; Gan J; He M; Zhang X; Chen X
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):127-144. PubMed ID: 36637699
[TBL] [Abstract][Full Text] [Related]
15. The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.
Langston RG; Rudenko IN; Cookson MR
Biochem J; 2016 Feb; 473(3):221-32. PubMed ID: 26811536
[TBL] [Abstract][Full Text] [Related]
16. Metabolic rescue of α-synuclein-induced neurodegeneration through propionate supplementation and intestine-neuron signaling in C. elegans.
Wang C; Yang M; Liu D; Zheng C
Cell Rep; 2024 Mar; 43(3):113865. PubMed ID: 38412096
[TBL] [Abstract][Full Text] [Related]
17. Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson's models.
Kim H; Perentis RJ; Caldwell GA; Caldwell KA
Cell Death Dis; 2018 May; 9(5):555. PubMed ID: 29748634
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Activity of Glutaredoxin 1 Protein (Grx1) in Colon Cancer.
Brzozowa-Zasada M; Piecuch A; Bajdak-Rusinek K; Gołąbek K; Michalski M; Matysiak N; Czuba Z
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256082
[TBL] [Abstract][Full Text] [Related]
19. Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients.
Fernández-Santiago R; Carballo-Carbajal I; Castellano G; Torrent R; Richaud Y; Sánchez-Danés A; Vilarrasa-Blasi R; Sánchez-Pla A; Mosquera JL; Soriano J; López-Barneo J; Canals JM; Alberch J; Raya Á; Vila M; Consiglio A; Martín-Subero JI; Ezquerra M; Tolosa E
EMBO Mol Med; 2015 Dec; 7(12):1529-46. PubMed ID: 26516212
[TBL] [Abstract][Full Text] [Related]
20. A liquid phase based C. elegans behavioral analysis system identifies motor activity loss in a nematode Parkinson's disease model.
Zheng M; Gorelenkova O; Yang J; Feng Z
J Neurosci Methods; 2012 Mar; 204(2):234-7. PubMed ID: 22108336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
